Growth Metrics

Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2025)

Historic Amortization - Intangibles for Collegium Pharmaceutical (COLL) over the last 7 years, with Q3 2025 value amounting to $55.5 million.

  • Collegium Pharmaceutical's Amortization - Intangibles rose 3595.99% to $55.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.9 million, marking a year-over-year increase of 5371.99%. This contributed to the annual value of $165.3 million for FY2024, which is 1340.83% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Amortization - Intangibles of $55.5 million as of Q3 2025, which was up 3595.99% from $55.5 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Amortization - Intangibles' 5-year high stood at $55.5 million during Q1 2025, with a 5-year trough of $16.8 million in Q1 2021.
  • Moreover, its 5-year median value for Amortization - Intangibles was $37.5 million (2023), whereas its average is $35.8 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Amortization - Intangibles surged by 15173.56% in 2022, and later plummeted by 1836.61% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Amortization - Intangibles (Quarter) stood at $16.8 million in 2021, then surged by 151.74% to $42.3 million in 2022, then decreased by 18.37% to $34.5 million in 2023, then skyrocketed by 60.72% to $55.5 million in 2024, then increased by 0.0% to $55.5 million in 2025.
  • Its Amortization - Intangibles stands at $55.5 million for Q3 2025, versus $55.5 million for Q2 2025 and $55.5 million for Q1 2025.